Collectively, these findings suggest that simple and widely available clinical parameters—such as serum albumin, ESR, ANA titers, and disease duration—may serve as practical tools to stratify the risk of polyautoimmunity in patients with autoimmune liver diseases. The gene discussed is ALB; the disease is autoimmune hepatitis.